Catalent bolsters biopharma business with Cook Pharmica buy

Tue, 19 Sep 2017 - 05:50 GMT

Catalent Inc agreed to buy Cook Pharmica LLC for $950 million in cash as the company doubles down on its growing business of supplying biologics to drugmakers.